Clinical Trials

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07241819 2025-11-21

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

66 enrolled

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer

NCT07200141 2025-09-30

SIB-NCRT-pumch

156 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT07177092 2025-09-16

SURGAN-TKI

118 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07162714 2025-09-09

STAR

30 enrolled

Rectal Neoplasms

NCT07145931 2025-08-28

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

24 enrolled

Head and Neck Cancer Squamous Cell Carcinoma

NCT07089199 2025-07-28

TitAN

34 enrolled

NSCLC

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

60 enrolled

Esophageal Neoplasms

NCT07038460 2025-06-26

NEO-LISI

134 enrolled

Resectable Non-small Cell Lung Cancer

NCT06646445 2025-06-13

PREMICES

60 enrolled

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT06998719 2025-05-31

ACCESS

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

76 enrolled

NSCLC

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT06837948 2025-02-20

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

160 enrolled

Locally Advanced Non-Small Cell Lung Cancer

NCT06814067 2025-02-07

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

80 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06751394 2024-12-27

TRACER

44 enrolled

Rectal Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT06578871 2024-09-03

SUPERIOR

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06109402 2023-12-19

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05993858 2023-08-15

PC-1

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

124 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05794750 2023-04-06

AK104-IIT-13

50 enrolled

Colorectal Neoplasms

NCT05648487 2022-12-16

HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis

46 enrolled